More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$29.90B
EPS
12.19
P/E ratio
25.8
Price to sales
1.76
Dividend yield
0.782%
Beta
0.841143
Previous close
$372.46
Today's open
$372
Day's range
$368.07 - $374
52 week range
$245 - $375.10
show more
CEO
Adam H. Schechter
Employees
71000
Headquarters
Burlington, NC
Exchange
New York Stock Exchange
Shares outstanding
81200000
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
OTraces Selects Labcorp to Perform Biomarker Testing for Florida Department of Health–Funded Prostate Cancer Study
DEERFIELD BEACH, Fla., Nov. 18, 2026 (GLOBE NEWSWIRE) -- OTraces, Inc., a diagnostics company developing proteomic blood tests for early cancer detection, today announced that it has selected Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, to perform reference laboratory testing for its Florida Department of Health–funded clinical trial evaluating the OTraces blood-based prostate cancer diagnostic platform.
GlobeNewsWire • 9 hours ago

Worried investors are paying up for these stocks — some with up to 49% upside, analysts say
Defensive sectors have beaten the S&P 500 by a wide margin in recent months, even though they are priced much higher relative to earnings estimates than the index.
Market Watch • 6 hours ago

Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo Fleury
Expansion will bring clinical trial services closer to research sites and patients while supporting global studies BURLINGTON, N.C., Nov. 17, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with Grupo Fleury, one of Brazil's leading healthcare and diagnostic groups, with extensive laboratory infrastructure, scientific expertise and a strong presence across the Brazil healthcare ecosystem, to expand clinical trial operations in the country.
PRNewsWire • Nov 17, 2026

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 17, 2026

Labcorp's Lab Growth Surges as $125 Million Reimbursement Risk Looms
Labcorp NYSE: LH Chief Financial Officer Julia Wang said strength in the company's central laboratory business and diagnostic testing helped drive third-quarter growth, while management prepares for a potential reduction in government reimbursement rates in 2027.
MarketBeat • Nov 13, 2026

Labcorp: 3 Key Takeaways for Long-Term Investors
Revenue grew 7% to $3.8 billion in the third quarter. Proposed Medicare fee schedule changes present a $125 million potential impact.
The Motley Fool • Nov 13, 2026

Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript
Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript
Seeking Alpha • Nov 11, 2026

Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?
LH's specialty testing growth, AI-driven efficiencies and expanding margins support its outlook, though currency pressures and competition pose risks.
Zacks Investment Research • Nov 10, 2026

Labcorp Holdings (LH) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 5, 2026

Labcorp to Speak at the UBS Global Healthcare Conference
BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10 at 8:45 a.m.
PRNewsWire • Nov 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Labcorp Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.